Home | Pharmaceutical Outsourcing - The Journal of Pharmaceutical & Biopharmaceutical Contract Services

Close Ad ☒

Show Ad

Hasty Decisions, Runaway Projects
Despite the best intentions of ISO and EMA, the pharma industry is still largely failing to exploit its data in a strategic, joined-up way - and this could now restrict companies’ ability to capitalize on AI. read more
Post-Approval Change Management
Achieving global approval for a single change may take three to five years, but inefficient lifecycle change management rarely registers as a crisis. read more
Five Steps to Smooth Agentic AI Adoption
In agentic AI-enabled labs, AI goes from individual, one-off applications to comprehensive workflow orchestration. read more
Leveraging AI and ML to Optimize Drug Discovery – a CRO Perspective
CROs supporting early-stage drug discovery projects are establishing their own internal AI platforms to address their clients’ needs in an evolving field. read more

Clinical Trials - Transforming Drug Development
Transforming Drug Development: Accelerating Clinical Trials through Patient-Centric Innovations and Technological Breakthroughs Watch Now

Lifecore Adds Seventh Late-Stage Commercial Manufacturing Program
Thursday, September 03, 2026
Lifecore Biomedical has signed an agreement with an undisclosed global pharmaceutical company to transfer manufacturing of a currently marketed ... read more
Fortrea Agrees to $45M Purchase of Worldwide Early-Phase Unit
Thursday, September 03, 2026
Fortrea Holdings has agreed to acquire the Early Phase Services division of Worldwide Clinical Trials in an all-cash transaction valued at about $45 ... read more
Northway Biotech Opens $72 Million Cell-Therapy CDMO in Vilnius
Thursday, September 03, 2026
Northway Biotech has opened a $72 million cell-therapy and personalized-medicine contract development and manufacturing facility in Vilnius, Lithuania... read more
ARPA-H Awards Up to $125M for Distributed RNA Medicine Manufacturing
Thursday, September 03, 2026
The Advanced Research Projects Agency for Health has selected five teams for a program intended to develop automated, distributed manufacturing ... read more
Evonik Invests $109 Million in Vancouver Lipid Drug Facility
Tuesday, September 01, 2026
Evonik will invest more than 150 million Canadian dollars, or about $109 million, to build a new good manufacturing practice drug-product facility in ... read more